https://pharmadog.xyz/news/514203 pharmadog en 2026-10-08T19:06:10.000Z Eli Lilly’s trillion-dollar market cap mirrors Dodgers’ big-spending dominance https://pharmadog.xyz/news/514204 pharmadog en 2026-10-08T19:05:19.000Z ARM playbook proposes data reuse to slash gene-editing R&D costs and broaden rare-disease therapies https://pharmadog.xyz/news/514011 pharmadog en 2026-10-08T18:55:11.000Z New PDUFA agreement earmarks funds to rehire FDA reviewers after recent layoffs https://pharmadog.xyz/news/514055 pharmadog en 2026-10-08T18:50:54.000Z NIH funding uncertainty clouds US research, dampens biotech investor sentiment https://pharmadog.xyz/news/514012 pharmadog en 2026-10-08T18:13:05.000Z Viatris to acquire Pacira BioSciences for $1.65 billion, expanding its non‑opioid pain portfolio https://pharmadog.xyz/news/513675 pharmadog en 2026-10-08T16:27:16.000Z Robotics biotech firm Multiply Labs raises $75M Series B as NorthStar secures up to $185M https://pharmadog.xyz/news/513739 pharmadog en 2026-10-08T16:00:00.000Z Viatris to acquire Pacira BioSciences for $1.65 billion, adding two non-opioid pain drugs https://pharmadog.xyz/news/513551 pharmadog en 2026-10-08T15:43:59.000Z AI tool for breast cancer risk moves to direct-to-consumer amid regulatory scrutiny of Utah sandbox https://pharmadog.xyz/news/513571 pharmadog en 2026-10-08T15:38:00.000Z Argenx shares tumble 15% after Phase 3 Sjögren’s study of Vyvgart halted for futility https://pharmadog.xyz/news/513443 pharmadog en 2026-10-08T15:31:38.000Z Democrats eye key House committees as midterms approach, opening doors for new health policy influence https://pharmadog.xyz/news/513399 pharmadog en 2026-10-08T15:30:49.000Z Ono Pharmaceutical pays Biohaven $80 million for protein degrader as UK pulls Valneva's chikungunya vaccine https://pharmadog.xyz/news/513400 pharmadog en 2026-10-08T15:29:56.000Z Endeavor BioMedicines reports mid-stage trial success for IPF drug, suggests disease reversal potential https://pharmadog.xyz/news/513463 pharmadog en 2026-10-08T15:23:00.000Z Caribou Biosciences explores strategic alternatives, drawing interest as a reverse-merger candidate https://pharmadog.xyz/news/513444 pharmadog en 2026-10-08T15:18:05.000Z Roche partners with Chinese biotech Defand Therapeutics to co-develop new medicines https://pharmadog.xyz/news/513401 pharmadog en 2026-10-08T15:12:53.000Z WHO and biotech firms turn attention to preeclampsia, a leading cause of maternal and newborn complications https://pharmadog.xyz/news/513423 pharmadog en 2026-10-08T15:08:54.000Z Argenx halts late-stage Vyvgart trial in Sjogren’s disease after futility finding, shares tumble 13% https://pharmadog.xyz/news/513445 pharmadog en 2026-10-08T15:02:53.000Z FDA extends safety review of mifepristone into next year, report due by March 2027 https://pharmadog.xyz/news/513402 pharmadog en 2026-10-08T15:02:27.000Z Grindr launches telehealth service offering erectile dysfunction and weight loss prescriptions https://pharmadog.xyz/news/513231 pharmadog en 2026-10-08T14:41:14.000Z Zealand and Roche report positive Phase 2 results for amylin drug petrelintide in obesity and diabetes https://pharmadog.xyz/news/513275 pharmadog en 2026-10-08T14:02:29.000Z Argenx's Vyvgart fails to beat placebo in Phase 3 Sjögren's disease trial https://pharmadog.xyz/news/513087 pharmadog en 2026-10-08T13:51:02.000Z Newron reports five deaths in schizophrenia trial as FDA keeps hold on evenamide study https://pharmadog.xyz/news/513088 pharmadog en 2026-10-08T13:40:59.000Z Zealand Pharma’s petrelintide shows 9% weight loss in Phase 2 but fails to improve blood sugar, analysts unimpressed https://pharmadog.xyz/news/513063 pharmadog en 2026-10-08T13:25:15.000Z General Medicine secures $120 million to launch all-in-one healthcare marketplace https://pharmadog.xyz/news/513107 pharmadog en 2026-10-08T13:15:33.000Z PhRMA sues Trump administration over Medicare price linking pilot program https://pharmadog.xyz/news/513089 pharmadog en 2026-10-08T13:04:15.000Z Matchpoint Therapeutics raises $150 million Series B to move oral T-cell modulator MPT-062 toward clinical trials https://pharmadog.xyz/news/512771 pharmadog en 2026-10-08T12:00:00.000Z Roche partners with China's Defand Therapeutics to discover molecular glue medicines https://pharmadog.xyz/news/512772 pharmadog en 2026-10-08T11:53:27.000Z All 2026 Nobel laureates in science are men, highlighting ongoing gender gap https://pharmadog.xyz/news/134233 pharmadog en 2026-10-08T11:48:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/512559 pharmadog en 2026-10-08T11:00:06.000Z Argenx halts Phase 3 Sjögren's trial as celiac disease data brings mixed results https://pharmadog.xyz/news/512415 pharmadog en 2026-10-08T09:52:54.000Z Venture debt becomes central financing option for late-stage European biotech https://pharmadog.xyz/news/513038 pharmadog en 2026-10-08T09:36:00.000Z Endeavor BioMedicines reports positive phase 2b results for Hedgehog inhibitor taladegib in IPF https://pharmadog.xyz/news/513039 pharmadog en 2026-10-08T08:46:00.000Z Iambic Therapeutics targets $135M IPO to fund clinical trials of HER2 and KIF18A cancer drugs https://pharmadog.xyz/news/512267 pharmadog en 2026-10-08T08:30:00.000Z Smaller biotech firms face uncertainty over U.S. tariff exemptions as new import taxes take effect https://pharmadog.xyz/news/512273 pharmadog en 2026-10-08T08:30:00.000Z Mother and daughter seek community for ultra-rare Nicolaides-Baraitser syndrome https://pharmadog.xyz/news/512268 pharmadog en 2026-10-08T08:30:00.000Z Democrats compete for new seats on House Energy and Commerce and Ways and Means committees after midterms https://pharmadog.xyz/news/512271 pharmadog en 2026-10-08T08:30:00.000Z Everlywell launches AI tool to predict breast cancer risk directly to consumers https://pharmadog.xyz/news/512272 pharmadog en 2026-10-08T08:30:00.000Z Tailored breast cancer care for older women gains momentum as researchers highlight age-specific tumor differences https://pharmadog.xyz/news/512270 pharmadog en 2026-10-08T08:30:00.000Z Experts say U.S. must step up to match Europe’s progress in eliminating hepatitis C https://pharmadog.xyz/news/512269 pharmadog en 2026-10-08T08:30:00.000Z CMS proposes changes to curb 340B drug discount program’s costly subsidies to safety-net hospitals https://pharmadog.xyz/news/511779 pharmadog en 2026-10-08T06:44:11.000Z Roche signs near-$1 billion partnership with Chinese biotech Defand on degrader therapies https://pharmadog.xyz/news/512366 pharmadog en 2026-10-08T05:25:00.000Z Ono Pharmaceutical pays $80 million for Asian rights to Biohaven IgG degrader trio, including phase-3 Graves disease candidate https://pharmadog.xyz/news/512367 pharmadog en 2026-10-08T04:34:00.000Z Zealand's amylin analog shows strong weight loss but weak blood-sugar control in phase 2 trial https://pharmadog.xyz/news/511467 pharmadog en 2026-10-08T04:31:00.000Z Rare disease biotech firms expand teams as FDA approvals boost pipelines https://pharmadog.xyz/news/511468 pharmadog en 2026-10-08T04:01:00.000Z Q3 biopharma layoffs drop 90% year-over-year, affecting about 1,800 workers https://pharmadog.xyz/news/512198 pharmadog en 2026-10-08T03:04:00.000Z Argenx’s FB102 meets primary endpoint in phase 2 celiac trial, paving way for pivotal study https://pharmadog.xyz/news/509947 pharmadog en 2026-10-07T21:00:00.000Z Optogenetics therapy restores light sensitivity in half of retinitis pigmentosa patients in early trial https://pharmadog.xyz/news/510470 pharmadog en 2026-10-07T20:19:00.000Z Eden Brothers recalls Calabrese broccoli seeds over possible Salmonella contamination https://pharmadog.xyz/news/509779 pharmadog en 2026-10-07T19:41:16.000Z Trump administration proposes $70,000 fee for OPT program, raising concerns for biotech talent pipeline https://pharmadog.xyz/news/509567 pharmadog en 2026-10-07T18:57:21.000Z PhRMA files lawsuit against Trump administration over GLOBE drug pricing demonstration program https://pharmadog.xyz/news/509568 pharmadog en 2026-10-07T18:24:16.000Z Ultragenyx sells priority review voucher for $210 million, retains another to monetize https://pharmadog.xyz/news/509569 pharmadog en 2026-10-07T18:21:47.000Z Dutch court orders Merck to halt subcutaneous Keytruda sales in eight European countries https://pharmadog.xyz/news/509570 pharmadog en 2026-10-07T18:05:41.000Z Zuckerberg’s Biohub secures $1.8 billion to expand AI-driven virtual cell platform with Meta and Google https://pharmadog.xyz/news/509399 pharmadog en 2026-10-07T18:00:31.000Z WHO advises against GLP-1 obesity drugs for children under 10, limits use in teens https://pharmadog.xyz/news/509275 pharmadog en 2026-10-07T16:58:32.000Z PhRMA sues Trump administration over Medicare GLOBE price pilot https://pharmadog.xyz/news/509019 pharmadog en 2026-10-07T15:37:00.000Z Caribou Biosciences halts CAR-T programs and cuts staff amid funding shortfall https://pharmadog.xyz/news/508955 pharmadog en 2026-10-07T15:24:58.000Z Bexorg receives $28 million ARPA-H grant to extend testing of revived human brain tissue https://pharmadog.xyz/news/509020 pharmadog en 2026-10-07T15:21:00.000Z Dutch court blocks Merck's subcutaneous Keytruda sales in eight European countries after Halozyme patent win https://pharmadog.xyz/news/508956 pharmadog en 2026-10-07T15:20:53.000Z Nuvig Therapeutics halts Phase 2 trial of NVG-2089 in chronic inflammatory demyelinating polyneuropathy https://pharmadog.xyz/news/508811 pharmadog en 2026-10-07T14:44:27.000Z Cerevance's solengepras cuts Parkinson off-time by 0.6 hours in Phase 3, advancing toward FDA review https://pharmadog.xyz/news/508831 pharmadog en 2026-10-07T14:06:29.000Z Dutch court blocks Merck's subcutaneous Keytruda in several European markets https://pharmadog.xyz/news/508787 pharmadog en 2026-10-07T14:03:57.000Z Novartis-partnered Matchpoint Therapeutics raises $150 million Series B to fund clinical entry https://pharmadog.xyz/news/508643 pharmadog en 2026-10-07T13:44:19.000Z ArriVent BioPharma's Phase 3 lung cancer trial misses primary endpoint, shares tumble https://pharmadog.xyz/news/508663 pharmadog en 2026-10-07T13:42:22.000Z Forbion secures $2.6 billion in its biggest European venture fund to date https://pharmadog.xyz/news/508664 pharmadog en 2026-10-07T13:38:52.000Z Utah health AI pilots face regulatory uncertainty as FDA scrutiny looms https://pharmadog.xyz/news/509374 pharmadog en 2026-10-07T12:58:00.000Z Cadrenal Therapeutics launches strategic review to explore sale or partnership for its late-stage cardiology pipeline https://pharmadog.xyz/news/508495 pharmadog en 2026-10-07T12:56:49.000Z WHO issues first global guidelines on childhood and adolescent obesity https://pharmadog.xyz/news/508475 pharmadog en 2026-10-07T12:24:13.000Z Biotech VC Forbion raises record €2.3 bn ($2.6 bn) to back 30 high-potential life-science companies https://pharmadog.xyz/news/508496 pharmadog en 2026-10-07T12:10:42.000Z DOJ expands fraud enforcement to include drug and device makers under FD&C Act https://pharmadog.xyz/news/508476 pharmadog en 2026-10-07T12:05:58.000Z Caribou Biosciences to halt R&D and cut staff as financing for allogeneic CAR-T dries up https://pharmadog.xyz/news/508515 pharmadog en 2026-10-07T12:01:00.000Z Cerevance reports positive Phase 3 results for Parkinson’s drug solengepras https://pharmadog.xyz/news/508451 pharmadog en 2026-10-07T12:00:43.000Z MimiVax's glioblastoma vaccine falls short of Phase 2b primary endpoint https://pharmadog.xyz/news/508452 pharmadog en 2026-10-07T12:00:40.000Z TCGX launches $600 million Asia-focused biotech fund to back life-science companies in China and the region https://pharmadog.xyz/news/508327 pharmadog en 2026-10-07T11:50:41.000Z ER visits by foreign-born patients fall sharply after increased ICE raids in Los Angeles https://pharmadog.xyz/news/123087 pharmadog en 2026-10-07T11:31:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/508308 pharmadog en 2026-10-07T11:27:00.000Z Bayer invests $2.2 billion in Ohio to build pharma manufacturing plant https://pharmadog.xyz/news/508930 pharmadog en 2026-10-07T11:27:00.000Z ARPA-H launches Surpass program to speed and broaden clinical trials https://pharmadog.xyz/news/508283 pharmadog en 2026-10-07T11:17:25.000Z CAR-T biotech Caribou Biosciences halts two programs and seeks exit after funding shortfall https://pharmadog.xyz/news/508159 pharmadog en 2026-10-07T10:42:28.000Z 2026 Nobel Chemistry Prize honors research on chiral molecules with implications for drug development https://pharmadog.xyz/news/508762 pharmadog en 2026-10-07T10:22:00.000Z TCGX raises $600 million to fund Asian biotech startups https://pharmadog.xyz/news/508763 pharmadog en 2026-10-07T10:10:00.000Z Cerevance's solengepras cuts OFF time in phase 3 Parkinson's trial https://pharmadog.xyz/news/507971 pharmadog en 2026-10-07T09:42:29.000Z Epkinly shows 51% lower risk of progression in frontline DLBCL trial, boosting hopes for expanded approval https://pharmadog.xyz/news/508594 pharmadog en 2026-10-07T09:10:00.000Z Atsena reports early efficacy signals for gene therapy ATSN-201 in X-linked retinoschisis trial https://pharmadog.xyz/news/507715 pharmadog en 2026-10-07T08:30:00.000Z Caribou Biosciences shuts down after failing to fund late-stage CAR-T lymphoma trial https://pharmadog.xyz/news/507716 pharmadog en 2026-10-07T08:30:00.000Z Experimental exon-skipping drug from Avidity Biosciences shows early improvement in a Duchenne patient https://pharmadog.xyz/news/507718 pharmadog en 2026-10-07T08:30:00.000Z Life insurers deem active-surveillance prostate cancer 'untreated' and deny term coverage, says patient https://pharmadog.xyz/news/507717 pharmadog en 2026-10-07T08:30:00.000Z Democrats court new Make America Healthy Again voters with food and environmental proposals https://pharmadog.xyz/news/508595 pharmadog en 2026-10-07T08:16:00.000Z Matchpoint Therapeutics raises $150M Series B to advance oral covalent therapies for autoimmune disease https://pharmadog.xyz/news/507191 pharmadog en 2026-10-07T05:01:00.000Z Executive candidates need full truth, not a sales pitch, to address company challenges https://pharmadog.xyz/news/507023 pharmadog en 2026-10-07T04:06:00.000Z Venture capital continues to flow into biopharma in Q3 2026, favoring later-stage and AI-driven companies https://pharmadog.xyz/news/508937 pharmadog en 2026-10-07T02:17:00.000Z Stryker appoints Spencer Stiles as CEO, Kevin Lobo to become Executive Chair https://pharmadog.xyz/news/510421 pharmadog en 2026-10-07T00:00:00.000Z EMA to revise pharmacogenomics guideline as MHRA adopts AI framework for medical devices https://pharmadog.xyz/news/506095 pharmadog en 2026-10-06T23:41:30.000Z Infectious disease expert urges calm over mysterious pneumonia case in Siberia